135 related articles for article (PubMed ID: 2402080)
1. [Molecular and immunological approach to hematological disease: detection and analysis of intracellular modified nucleosides by flow cytometry].
Hoshino A; Honda I; Ishimori A; Itoh K; Mizugaki M; Nose M
Rinsho Byori; 1990 Jul; 38(7):756-64. PubMed ID: 2402080
[TBL] [Abstract][Full Text] [Related]
2. Pyrimidine nucleoside, pseudouridine, and modified nucleoside excretion by growing and resting fibroblasts.
Uziel M; Selkirk JK
J Cell Physiol; 1979 May; 99(2):217-22. PubMed ID: 457787
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical analysis for cancer of the esophagus using monoclonal antibodies specific for modified nucleosides.
Masuda M; Nishihira T; Itoh K; Mizugaki M; Ishida N; Mori S
Cancer; 1993 Dec; 72(12):3571-8. PubMed ID: 8252470
[TBL] [Abstract][Full Text] [Related]
4. Determination of degradation rates of transfer and ribosomal ribonucleic acids in cultured rat hepatocytes by measuring N6-threoninocarbonyladenosine, dihydrouridine, and pseudouridine in medium using high-performance liquid chromatography.
Topp H; Dörrenhaus A; Bolt H; Schöch G; Föllmann W
Anal Biochem; 1997 Dec; 254(2):200-7. PubMed ID: 9417777
[TBL] [Abstract][Full Text] [Related]
5. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer].
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM
Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic use of anti-modified nucleoside monoclonal antibody.
Itoh K; Ishiwata S; Ishida N; Mizugaki M
Tohoku J Exp Med; 1992 Oct; 168(2):329-31. PubMed ID: 1306318
[TBL] [Abstract][Full Text] [Related]
7. Relationship of urinary pseudouridine and 1-methyladenosine to activity of leukemia and lymphoma.
Itoh K; Konno T; Sasaki T; Ishiwata S; Ishida N; Misugaki M
Clin Chim Acta; 1992 Mar; 206(3):181-9. PubMed ID: 1606704
[TBL] [Abstract][Full Text] [Related]
8. Serum pseudouridine as a biochemical marker in small cell lung cancer.
Tamura S; Fujioka H; Nakano T; Hada T; Higashino K
Cancer Res; 1987 Nov; 47(22):6138-41. PubMed ID: 2822241
[TBL] [Abstract][Full Text] [Related]
9. [Serum 1-methyladenosine and pseudouridine as tumor markers in tumor-bearing mice].
Ishiwata S; Itoh K; Yamaguchi T; Sasaki S; Ishida N; Mizugaki M
Yakugaku Zasshi; 1995 Jul; 115(7):523-7. PubMed ID: 7562399
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of RNA containing O-beta-D-ribofuranosyl-(1''-2')-adenosine-5''-phosphate and 1-methyladenosine, minor components of tRNA.
Mikhailov SN; Efimtseva EV; Rodionov AA; Shelkunova AA; Rozenski J; Emmerechts G; Schepers G; Van Aerschot A; Herdewijn P
Chem Biodivers; 2005 Sep; 2(9):1153-63. PubMed ID: 17193197
[TBL] [Abstract][Full Text] [Related]
11. Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis.
Jeng LB; Lo WY; Hsu WY; Lin WD; Lin CT; Lai CC; Tsai FJ
Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1543-9. PubMed ID: 19399767
[TBL] [Abstract][Full Text] [Related]
12. Pseudouridine: a modified nucleoside as biological marker in malignant lymphomas.
Rasmuson T; Björk GR
Cancer Detect Prev; 1983; 6(1-2):293-6. PubMed ID: 6883387
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the advantage of determination of urinary pseudouridine for the early detection of a malignant transformation process].
Senden D; Buchet JP; Lauwerys R
J Toxicol Clin Exp; 1990; 10(7-8):473-80. PubMed ID: 2135063
[TBL] [Abstract][Full Text] [Related]
14. Urinary pseudouridine as a biochemical marker in the diagnosis and monitoring of primary hepatocellular carcinoma.
Tamura S; Fujioka H; Nakano T; Amuro Y; Hada T; Nakao N; Higashino K
Am J Gastroenterol; 1988 Aug; 83(8):841-5. PubMed ID: 2456010
[TBL] [Abstract][Full Text] [Related]
15. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
16. [Excretion of normal and modified RNA catabolites and creatinine in the urine as a function of nutrition in children].
Schöch G; Heller-Schöch G; Müller J; Clemens P; Holtgrewe A; Heddrich M
Monatsschr Kinderheilkd; 1983 May; 131(5):259-63. PubMed ID: 6192333
[TBL] [Abstract][Full Text] [Related]
17. Modified nucleosides in patients with acquired immune deficiency syndrome (AIDS) and individuals at high risk of AIDS: correlations with lymphadenomegaly and immunological parameters.
Fischbein A; Bekesi JG; Solomon S; Borek E; Sharma OK
Cancer Detect Prev Suppl; 1987; 1():589-96. PubMed ID: 3500786
[TBL] [Abstract][Full Text] [Related]
18. [Immunophenotypic analysis of lymphocyte subpopulation and hematological malignancies].
Kawai Y; Ujiie M; Amano H; Sonoda A; Watanabe K
Rinsho Byori; 1995 Sep; 43(9):931-9. PubMed ID: 7474457
[TBL] [Abstract][Full Text] [Related]
19. Creatinine at the evaluation of urinary 1-methyladenosine and pseudouridine excretion.
Honda I; Itoh K; Mizugaki M; Sasaki T
Tohoku J Exp Med; 1999 Jun; 188(2):133-8. PubMed ID: 10526874
[TBL] [Abstract][Full Text] [Related]
20. The use of receiver operating characteristic (ROC) curves analysis in the evaluation of the diagnostic efficiency of serum pseudouridine as a tumor marker.
Savoia M; Pane F; Fortunato G; Salvatore F; Sacchetti L
Ital J Biochem; 1988; 37(2):119-27. PubMed ID: 3403212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
